uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted May 18, 2012

Caution with Butterbur Indicated by UK Warning

England's Medicines and Healthcare Products Regulatory Agency (MHRA) advised consumers in early 2012 not to take unlicensed butterbur (Petasites hybridus) herbal products due to potential health risks. The MHRA noted that butterbur contains pyrrolizidine alkaloids (PAs) which studies have shown can result in serious liver damage and organ failure. PAs have also been shown to lead to cancer in animals. Butterbur is most commonly used to treat migraine and hayfever.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at